| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a6017fcfbea1238fe048984cced54c3f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1c9c5b55acadf2c345aeba900ace297 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6897 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6897
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-6883
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-06 |
| filingDate |
1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_53192a88d6bdaa3d2ff19cc8cb257a30 |
| publicationDate |
2001-04-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-0127272-A1 |
| titleOfInvention |
Oculomedin and glaucoma |
| abstract |
Nucleic acids encoding oculomedin polypeptide are disclosed. Also described are related nucleic acids encoding oculomedin polypeptides, oculomedin polypeptides; antibodies that bind to oculomedin polypeptides, methods of diagnosis of glaucoma; assays for agents that alter the activity of oculomedin polypeptide or which identify oculomedin binding partners or assess the strength of an interaction between oculomedin and an oculomedin binding partner, and the agents or binding partners identified by the assays; pharmaceutical compositions comprising the oculomedin nucleic acids, oculomedin polypeptides, or agents that alter the activity of the oculomedin polypeptides; as well as methods of therapy of glaucoma. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7796966-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7488802-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7521051-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004056875-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8088905-B2 |
| priorityDate |
1999-10-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |